Mariner’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
Mariner's IHE Position: Q2 2026 in Review
Mariner reduced its iShares US Pharmaceuticals ETF (IHE) stake by 0.59% in Q2 2026, selling an estimated $13.2K and leaving 24,775 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1367.
Mariner first reported a position in IHE in Q3 2016 and has held it in 19 quarters since. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- Mariner held 24,775 shares of iShares US Pharmaceuticals ETF worth $2.45M as of Q2 2026.
- Mariner sold 147 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $13.2K.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1367 holding.
- Mariner first reported a position in iShares US Pharmaceuticals ETF in Q3 2016 and has held it in 19 quarters since.
- 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.